跳至主要内容
临床试验/NCT04437069
NCT04437069进行中(未招募)不适用

Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making

University of Utah2 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2020年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
135
试验地点
2
主要终点
Change in the Brief Symptom Inventory (BSI) Global Severity Index of Global Distress

研究概览

简要总结

This study is a randomized clinical trial where participants (parents of a fetus or neonate diagnosed with a life-threatening congenital heart disease (CHD)) will randomly be assigned to either receiving a web-based decision aid (DA) alone, or receiving the decision aid that includes a values clarification exercise. Because of the novel use of decision aids in CHD in an acute setting, we will also compare participants receiving the DA in a randomized control trial to a prospective observational population of families faced with similar decisions without a DA (control group). We have designated the Brief Symptom Inventory Global Severity Index of Global Distress 3 months post-birth or death/termination as our primary outcome measure.

详细描述

The diagnosis of a life-threatening pediatric heart condition impacts both the future of a child and the health and quality of life of the family. Parents of a child with this diagnosis are faced with the stress of comprehending extensive information about the diagnosis and treatment options, and are required to make immediate and profound choices about interventions that will have long-lasting repercussions. To provide the best care at this challenging time, it is crucial to find methods to improve parent-provider shared decision making (SDM) and to encourage the inclusion of both patient-centered and family-centered outcomes. One method commonly used to improve SDM are decision aids (DA). DAs are designed to 1) provide accurate and balanced information; 2) clarify patients' values; and 3) improve SDM skills. A Cochrane review showed that DAs contribute to effective SDM by: 1) increasing knowledge of the diagnosis and treatment options, 2) increasing patient and practitioner participation in SDM, 3) reducing uncertainty and decisional conflict, 4) improving concordance between preference and treatment received, and 5) improving patient-provider communication.

Values clarification exercises (VCE) are occasionally included in DAs to help patients clarify their values about the treatment decision. Although these exercises are often used, they are poorly tested. Previous systematic reviews have failed to identify rigorous research studies to answer questions regarding whether VCE improves patient decision making processes. This project aims to determine the impact of the DA with and without the VCE on longitudinal parent mental health, decision quality and perceptions of patient-provider communication. Specifically, we will test the impact of decision aids (DA vs. no DA, and DA with and without the VCE) on mental health outcomes (e.g., anxiety, complicated grief), decision quality (e.g., quality of the decision, parent-provider communication), and provider experience (e.g., satisfaction with interacting with patients who used the tool). In the development of the DA and VCE, we conducted focus groups and interviews in Utah, Illinois, Washington, D.C, and North Carolina with parents whose fetus/neonate had been diagnosed with complex CHD. The main goal of this study is to determine the impact of the DA with and without the VCE on longitudinal parent mental health, decision quality and provider experience.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Parents whose fetus/neonate was diagnosed with a life-threatening CHD that meets eligibility criteria below without restriction based on gender, race, age, or socioeconomic status.
  • We will request participation from both parents but will not disqualify families if only one parent participates.
  • Eligibility Criteria: Parents whose fetus/neonate was diagnosed with a life-threatening CHD that are offered the choice between intervention and comfort care (and in some cases termination). This is limited to the following diagnoses: Truncus Arteriosus, Pulmonary Atresia with Intact Ventricular Septum, Complex Single Ventricle, Complex Single Ventricle with Heterotaxy, Hypoplastic Left Heart Syndrome (HLHS), and Ebstein's Anomaly of the Tricuspid Valve.

排除标准

  • Patients with other types of CHD that are not listed above are not eligible.
  • Participants must be 18 years of age or older

研究组 & 干预措施

Standard Care (Control)

No Intervention

Participants will receive standard care and will not view either the Decision Aid or the Values Clarification Exercise

Decision Aid

Experimental

Participants view the Decision Aid only

干预措施: Decision Aid (Other)

Decision Aid & Values Clarification Exercise

Experimental

Participants view both the Decision Aid and the Values Clarification Exercise

干预措施: Decision Aid (Other)

Decision Aid & Values Clarification Exercise

Experimental

Participants view both the Decision Aid and the Values Clarification Exercise

干预措施: Values Clarification Exercise (Other)

结局指标

主要结局

Change in the Brief Symptom Inventory (BSI) Global Severity Index of Global Distress

时间窗: 1 week post baseline & 3 months post-decision

The BSI is a validated scale of 53 questions that indicate the degree of stress the participant has experienced within the previous seven days. Answers range in a 5 point Likert scale from 0=not at all to 4=extremely. The scale measures stress, so a lower score is better. Scores are obtained for nine primary symptom dimensions and three global indices of distress. The primary comparison is the baseline measurement versus 3 months post-decision measurement. We are looking at how those measurements changed.

次要结局

  • Decision Quality - Values(1 week Post-Decision Aid, 1 month post-decision, & 3 months post-decision)
  • Brief Symptom Inventory (BSI) Global Severity Index of Global Distress(1 week Post-Decision Aid, 1 month post-decision)
  • Decision Quality - Knowledge(1 week Post-Decision Aid, 1 month post-decision, & 3 months post-decision)
  • Perinatal Grief(1 week Post-Decision Aid, 1 month post-decision, & 3 months post-decision)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Angie Fagerlin

Professor & Chair, Department of Population Health Sciences

University of Utah

研究点 (2)

Loading locations...

相似试验